ThursdayJun 27, 2024 10:00 am

Older Psychedelics Users Reveal Fascinating Brain Function, Study Says

Scientific interest in psychedelics has increased greatly over the past few years as more and more trials determine that these substances possess the therapeutic potential to treat disorders such as post traumatic stress disorder (PTSD), depression or anxiety. Substances with the most promising results include LSD, psilocybin, MDMA and ketamine. Now, results from a recently conducted survey show that psychedelic drugs such as LSD, MDMA and psilocybin may help protect the brain from some features of aging. The survey was carried out in the United States and involved 3,294 adults, all aged between 42 and 92 years of age. The…

Continue Reading

TuesdayJun 25, 2024 10:00 am

Analyzing Possible Industry Implications of FDA Advisory Panel Decision on MDMA

About a week ago, an advisory committee to the U.S. Food and Drug Administration (FDA) rejected evidence supporting the approval of MDMA as an alternative treatment for post-traumatic stress disorder (PTSD). This is a deflating moment for many in psychedelic research who have, for years, conducted trials on the drug in an effort to gain approval for commercial distribution. The application reviewed by the advisory committee was presented by Lykos Therapeutics, which concluded phase 2 and 3 trials investigating the effectiveness of MDMA-assisted therapy in managing post-traumatic stress disorder. In their report, the advisors revealed that they went through the…

Continue Reading

ThursdayJun 20, 2024 10:00 am

UC Berkeley Research to Investigate How Psychedelics Alter People’s Views

Psychedelic fungi and plants have been used by various Indigenous communities in their healing and spiritual ceremonies for millennia. In the 1950s and 1960s, western therapists, psychiatrists and researchers began looking into whether these drugs could be used to manage mental-health conditions. However, the approval of the Controlled Substances Act halted this research, up until about a decade ago. Now, researchers at the UC Berkeley Center for the Science of Psychedelics are set to begin a study looking into how psychedelic substances shape how humans perceive things. Previous research has determined that the effects of these drugs on an individual’s…

Continue Reading

TuesdayJun 18, 2024 10:00 am

Study Suggests Psychedelics Reduce Fear of Death by Impacting Metaphysical Beliefs

Therapeutic interest in psychedelics has grown as researchers learn more about the potential of these substances to manage the symptoms of different mental-health conditions and improve the well-being of individuals. Now, new research has determined that psychedelic experiences can cause a decrease in death anxiety, possibly by changing a person’s metaphysical beliefs. This discovery creates new approaches for understanding how these substances may help people deal with existential fears. For their study, researchers focused on determining if changes in core beliefs on consciousness and the nature of reality could be a key factor in decreasing death anxiety after psychedelics were…

Continue Reading

ThursdayJun 13, 2024 10:00 am

Study Finds That Psychedelics, Religion Weaken Link to Risky Behavior and Violence

Classic psychedelics are drugs that induce altered states of consciousness and intense auditory and visual hallucinations when ingested. Common classic psychedelics include psilocybin, LSD, DMT and mescaline. These drugs have been used for centuries by Indigenous peoples in spiritual ceremonies and healing practices. In most countries, psychedelics are illegal. Despite their status, various studies have determined that these drugs hold promise in the treatment of conditions such as anxiety, depression and post-traumatic stress disorder (PTSD). Now, new research has determined that the link between violence and risky behaviors is weaker among individuals who report lifetime psychedelic use as well as…

Continue Reading

TuesdayJun 11, 2024 10:00 am

Psychedelic Stocks Fall as Advisory Panel Tells FDA Not to Approve MDMA

A number of companies involved in the psychedelic space saw their stocks plummet during premarket trading earlier this week after an advisory panel counseled the U.S. Food and Drug Administration (FDA) against approving the use of MDMA as a treatment for post traumatic stress disorder (PTSD). MDMA, commonly known as molly or ecstasy, is a stimulant and psychedelic drug that comes in powder or pill forms. Currently, the drug is classified under Schedule I of the Controlled Substances Act, together with drugs such as LSD, marijuana, heroin and peyote. Drugs under this classification are said to have no accepted medical…

Continue Reading

ThursdayJun 06, 2024 10:00 am

Case Study Documents Psychedelics Aiding Patient’s Recovery from Long-COVID

Long-COVID, also referred to as post-acute sequelae of SARS-CoV-2 infection, includes various symptoms that persist even after an individual recovers from the COVID-19. These symptoms include cognitive impairment, fatigue, depression, anxiety, headaches and joint pain. Currently, effective treatment options for long-COVID are limited. However, a new case study has examined how one patient suffering from long-COVID used MDMA and psilocybin to manage her symptoms. Psilocybin is the primary psychoactive compound found in hallucinogenic mushrooms. It has been used by indigenous cultures for spiritual ceremonies for centuries. In the last few years, scientific research has discovered that psilocybin has therapeutic benefits…

Continue Reading

TuesdayJun 04, 2024 10:00 am

Could Psychedelics Help Individuals Who Stutter?

A new study looking into the effect of psychedelics on individuals who stutter has determined that the drugs may have some benefits. The documented effects of classic psychedelic drugs such as LSD or psilocybin mushrooms are plenty, with researchers noting that their positive effects can be a rich study area. Eric S. Jackson, an associate professor of communicative disorders and sciences, states that investigating the possible effects of psychedelics on stuttering can be positive, particularly since the drugs have already shown potential in the management of conditions such as post-traumatic stress disorder and anxiety. Stuttering is basically intermittent disruptions in…

Continue Reading

PsychedelicNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 415.949.5050